AlphaStocks
5.0
Consider Buy

Addus HomeCare Corp (ADUS)

As of Sep 20, 2026, Addus HomeCare Corp (ADUS) scores 5.0/10 on AlphaStocks' five-model composite, #107 of 168 Health Care stocks. At $117, ADUS trades 13% below its model fair value of $134.

Health Care / Health Care Services

S&P SmallCap 600

$117.03

Below average on several measures. Research carefully.

Consider Buy

Score based on 4 of 5 models — moderate confidence

Data as of Sep 20, 2026

#107out of 168 in Health Care

Is Addus HomeCare Corp a Good Investment in 2026?

Addus HomeCare Corp (ADUS) scores 5.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Addus HomeCare Corp as Strong (7/9). However, the Graham model rates it Caution — 30% above fair value. Addus HomeCare Corp currently trades 13% below its estimated fair value of $134. Addus HomeCare Corp ranks #107 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E22.4ROE9.0Market Cap2B

Estimated Fair Value

$134.4313% below

Trading below estimated fair value. EPS grew 23% year-over-year. P/E of 22x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Neutral

Business quality & competitive moat

Graham

Caution

30% above fair value

Lynch

Attractive

PEG 2.6 · Stalwart

Greenblatt

Limited Data

Earnings yield + return on capital

Frequently Asked Questions

Is Addus HomeCare Corp (ADUS) a good investment?
As of Sep 20, 2026, Addus HomeCare Corp (ADUS) scores 5.0/10 on AlphaStocks' five-model composite, #107 of 168 Health Care stocks. At $117, ADUS trades 13% below its model fair value of $134. That score is below average, suggesting caution.
What is Addus HomeCare Corp's Piotroski F-Score?
Addus HomeCare Corp's Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ADUS overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $134, ADUS appears undervalued. The stock currently trades 13% below its estimated fair value. Trading below estimated fair value. EPS grew 23% year-over-year. P/E of 22x is moderate for this quality level.
How does ADUS compare to other Health Care stocks?
Addus HomeCare Corp ranks #107 out of 168 stocks in the Health Care sector, placing it in the top 64% of its sector by composite score. There are higher-ranked alternatives in this sector worth exploring.
What do investment models say about ADUS?
AlphaStocks evaluates ADUS using five proven investment models. Piotroski: Strong; Buffett: Neutral; Graham: Caution; Lynch: Attractive. These models are combined into a single composite score of 5.0/10.

Similar Stocks

DVAMDDGX

Compare ADUS with

ADUS vs DVAADUS vs MDADUS vs DGXADUS vs VAL

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer